BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 7922299)

  • 1. Hereditary C1q deficiency and systemic lupus erythematosus.
    Bowness P; Davies KA; Norsworthy PJ; Athanassiou P; Taylor-Wiedeman J; Borysiewicz LK; Meyer PA; Walport MJ
    QJM; 1994 Aug; 87(8):455-64. PubMed ID: 7922299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1q and systemic lupus erythematosus.
    Walport MJ; Davies KA; Botto M
    Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical variability and characteristic autoantibody profile in primary C1q complement deficiency.
    Vassallo G; Newton RW; Chieng SE; Haeney MR; Shabani A; Arkwright PD
    Rheumatology (Oxford); 2007 Oct; 46(10):1612-4. PubMed ID: 17890276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
    Jönsson G; Sjöholm AG; Truedsson L; Bengtsson AA; Braconier JH; Sturfelt G
    Rheumatology (Oxford); 2007 Jul; 46(7):1133-9. PubMed ID: 17478473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
    J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
    Sjoholm AG; Martensson U; Sturfelt G
    J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary C1q deficiency: a new family with C1qA deficiency.
    Sun-Tan C; Ozgür TT; Kilinç G; Topaloğlu R; Gököz O; Ersoy-Evans S; Sanal O
    Turk J Pediatr; 2010; 52(2):184-6. PubMed ID: 20560256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies.
    Botto M; Dell'Agnola C; Bygrave AE; Thompson EM; Cook HT; Petry F; Loos M; Pandolfi PP; Walport MJ
    Nat Genet; 1998 May; 19(1):56-9. PubMed ID: 9590289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of C1q deficiency on the severity and outcome of childhood systemic lupus erythematosus.
    Al-Mayouf SM; Abanomi H; Eldali A
    Int J Rheum Dis; 2011 Feb; 14(1):81-5. PubMed ID: 21303486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S; Vanhecke D; Trendelenburg M
    Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.